Immunization, Hib3 in Latin America & Caribbean

Latin America & Caribbean: Immunization, Hib3 was 81.8% in 2024. ◆ Volatile

Latest (2024)
81.8%
Change on year
down 1.3%
Rank
22nd
of 43 groups
All-time high
92.2%
in 2005
All-time low
0.0%
in 1990
Years of data
35
1990–2024

Immunization, Hib3 in Latin America & Caribbean, 1990–2024

0204060801001990200720241990: 0 % of children ages 12-23 months1991: 0 % of children ages 12-23 months1992: 0 % of children ages 12-23 months1993: 0 % of children ages 12-23 months1994: 0 % of children ages 12-23 months1995: 0 % of children ages 12-23 months1996: 2.2 % of children ages 12-23 months1997: 2.6 % of children ages 12-23 months1998: 11.2 % of children ages 12-23 months1999: 17.4 % of children ages 12-23 months2000: 69 % of children ages 12-23 months2001: 71.9 % of children ages 12-23 months2002: 76.4 % of children ages 12-23 months2003: 82.1 % of children ages 12-23 months2004: 86.8 % of children ages 12-23 months2005: 92.2 % of children ages 12-23 months2006: 91.2 % of children ages 12-23 months2007: 90.7 % of children ages 12-23 months2008: 90.5 % of children ages 12-23 months2009: 92.1 % of children ages 12-23 months2010: 91.5 % of children ages 12-23 months2011: 91 % of children ages 12-23 months2012: 91.4 % of children ages 12-23 months2013: 90.1 % of children ages 12-23 months2014: 89.1 % of children ages 12-23 months2015: 89.7 % of children ages 12-23 months2016: 89.2 % of children ages 12-23 months2017: 83.3 % of children ages 12-23 months2018: 84.6 % of children ages 12-23 months2019: 80.1 % of children ages 12-23 months2020: 76.2 % of children ages 12-23 months2021: 75.2 % of children ages 12-23 months2022: 78.7 % of children ages 12-23 months2023: 82.9 % of children ages 12-23 months2024: 81.8 % of children ages 12-23 months

Source: WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/). Measured in % of children ages 12-23 months.

Analysis

Latin America & Caribbean recorded 81.8% for immunization, hib3 in 2024.

That represents a change of down 1.3% on the previous year and down 8.2% over ten years.

Over the whole period, immunization, hib3 in Latin America & Caribbean peaked at 92.2% in 2005 and was at its lowest, 0.0%, in 1990.

Latin America & Caribbean ranks 22nd of 43 groups on this measure, in the middle of the range.

The series is highly variable year to year, so single readings are best treated with caution.

Immunization, Hib3 in Latin America & Caribbean, year by year

Annual values for Immunization, Hib3 (% of children ages 12-23 months) in Latin America & Caribbean, 1990 to 2024.
Year % of children ages 12-23 months Change
1990 0.0%
1991 0.0%
1992 0.0%
1993 0.0%
1994 0.0%
1995 0.0%
1996 2.2%
1997 2.6% +15.9%
1998 11.2% +330.0%
1999 17.4% +54.9%
2000 69.0% +297.1%
2001 71.9% +4.2%
2002 76.4% +6.2%
2003 82.1% +7.5%
2004 86.8% +5.7%
2005 92.2% +6.3%
2006 91.2% -1.1%
2007 90.7% -0.5%
2008 90.5% -0.2%
2009 92.1% +1.7%
2010 91.5% -0.6%
2011 91.0% -0.6%
2012 91.4% +0.5%
2013 90.1% -1.4%
2014 89.1% -1.1%
2015 89.7% +0.6%
2016 89.2% -0.5%
2017 83.3% -6.6%
2018 84.6% +1.5%
2019 80.1% -5.3%
2020 76.2% -4.9%
2021 75.2% -1.2%
2022 78.7% +4.6%
2023 82.9% +5.3%
2024 81.8% -1.3%

Biggest year-on-year movements

Years where Immunization, Hib3 in Latin America & Caribbean changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.

YearChange FromTo
1998 +330.0% 2.6% 11.2%
2000 +297.1% 17.4% 69.0%
1999 +54.9% 11.2% 17.4%

Averages by decade

DecadeAverage LowestHighest Years
1990s 3.3% 0.0% 17.4% 10
2000s 84.3% 69.0% 92.2% 10
2010s 88.0% 80.1% 91.5% 10
2020s 79.0% 75.2% 82.9% 5

Countries ranked near Latin America & Caribbean

  1. 20 Andorra 98.0% compare
  2. 20 Belarus 98.0% compare
  3. 20 Bhutan 98.0% compare
  4. 20 Guyana 98.0% compare
  5. 20 Iran, Islamic Republic of 98.0% compare
  6. 20 Israel 98.0% compare
  7. 20 Kazakhstan 98.0% compare
  8. 20 Rwanda 98.0% compare
  9. 20 Turkmenistan 98.0% compare

See the full ranking of 234 places →

More health data for Latin America & Caribbean

All data for Latin America & Caribbean →

Frequently asked questions

What is immunization, hib3 in Latin America & Caribbean?
Immunization, hib3 in Latin America & Caribbean was 81.8% in 2024, according to WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/).
What is the highest immunization, hib3 recorded in Latin America & Caribbean?
The highest recorded value was 92.2% in 2005.
What is the lowest immunization, hib3 recorded in Latin America & Caribbean?
The lowest recorded value was 0.0% in 1990.
How does Latin America & Caribbean rank for immunization, hib3?
Latin America & Caribbean ranks 22nd out of 43 groups with data for 2024.
Is immunization, hib3 rising or falling in Latin America & Caribbean?
Over the last ten years it is down 8.2%. The long-run trend across the full record is volatile.
Where does this Latin America & Caribbean data come from?
The figures come from WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as part of Immunization, Hib3 (% of children ages 12-23 months). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 35 observations, free to reuse under CC BY 4.0 (World Bank Open Data).

Share, cite or embed this page

Cite this page

Immunization, Hib3 in Latin America & Caribbean. Statizoid, drawing on WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/). Retrieved 16 September 2026, from https://health.statizoid.com/stat/immunization-hib3-percent-of-children-ages-12-23-months/latin-america-and-caribbean/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://health.statizoid.com/stat/immunization-hib3-percent-of-children-ages-12-23-months/latin-america-and-caribbean/">Immunization, Hib3 in Latin America & Caribbean</a> — Statizoid

About this data

Indicator
Immunization, Hib3 (% of children ages 12-23 months)
Unit
% of children ages 12-23 months
Source
WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/)
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
234 places, 5,441 data points, 1990–2024
Last refreshed

Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.